Elinx Pharmaceuticals India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.19 M
- Revenue Growth 152.04%
- Profit Growth 334.43%
- Ebitda 1110.66%
- Net Worth 20.27%
- Total Assets 84.65%
About Elinx Pharmaceuticals India
Elinx Pharmaceuticals India Private Limited (EPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 October 2012 and has a history of 12 years and three months. Its registered office is in Bagalkot, Karnataka, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.19 M.
Manjunath Konnur, Vijayakumar Hosatti, and Kalyanappa Masali serve as directors at the Company.
Company Details
- Location
Bagalkot, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232KA2012PTC066497
- Company No.
066497
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Oct 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
What products or services does Elinx Pharmaceuticals India Private Limited offer?
Elinx Pharmaceuticals India Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Mineral Supplement, Diabetes Medicine, Metformin Tablets, Multivitamin Tablets & Capsules.
Who are the key members and board of directors at Elinx Pharmaceuticals India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manjunath Konnur  | Director | 28-May-2022 | Current |
| Vijayakumar Hosatti | Director | 29-Oct-2012 | Current |
| Kalyanappa Masali | Director | 29-Oct-2012 | Current |
Financial Performance of Elinx Pharmaceuticals India.
Elinx Pharmaceuticals India Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 152.04% increase. The company also saw a substantial improvement in profitability, with a 334.43% increase in profit. The company's net worth Soared by an impressive increase of 20.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Elinx Pharmaceuticals India?
In 2017, Elinx Pharmaceuticals India had a promoter holding of 78.00% and a public holding of 22.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.19 M
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 0.12 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Feb 2022 | Indian Bank | ₹0.24 M | Open |
| 16 Jul 2021 | Indian Bank | ₹0.95 M | Open |
How Many Employees Work at Elinx Pharmaceuticals India?
Unlock and access historical data on people associated with Elinx Pharmaceuticals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Elinx Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elinx Pharmaceuticals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
